Bluestar Adisseo Co

Bluestar Adisseo Co

600299 · SHG · Basic Materials / Specialty Chemicals

8.20CNY-0.05 (-0.61%)

Price History

Full chart

Market Stats

Previous Close8.25
Open8.22
Day Range8.14 – 8.33
52-Week Range7.58 – 16.48
Volume18.35M
Market Cap25.28B
P/E (TTM)18.66
Forward P/E78.13
EPS0.44
Dividend Yield1.84%
Beta0.27
50-Day Avg8.43
200-Day Avg10.38

About

Bluestar Adisseo Company, together with its subsidiaries, engages in the research, development, production, and sale of poultry, ruminant, swine, and aquaculture nutrition additives. The company also offers mycotoxin management and palatability comprising, Unike Plus, Unike, Oxy-Nil, Mold-Nil, Salmo-Nil, Toxy-Nil, Krave AP, Optisweet, Gusti Plus, Maxarome, Delistart, Pepsea, Nutri-Bind Aqua, and Oxy-Nil Aqua Zero; enzymes and emulsifiers, including Rhodimet AT88 and Rhodimet; antioxidants and health by nutrition products, comprising Rhodimet AT88, Rhodimet NP99, Microvit A Supra 1000, and Microvit E Promix 50; milk production product, such as MetaSmart; and sulfur-based products, which includes Rhodimet AT88, Rhodimet® NP99, Microvit A Supra 1000, and Microvit E Promix 50. In addition, the company offers mycotoxin management products, such as Unike Plus, Unike, Toxy-Nil, Krave AP, Optisweet, Gusti Plus, Maxarome, and Delistart, as well as essential nutrient products, such as Rhodimet AT88, a hydroxy-methionine in liquid form; and Microvit A Supra 1000 to deliver performance; Microvit E Promix 50, a specialized nutritional supplement of vitamin E; and AdiSodium, which helps monogastrics to livestock management. Further, it provides various services consisting of PNE, a near infra-red spectroscopy technology; MYCOMAN for the management of mycotoxins; ADICT, a nutritional values calculation tool; Predictor, a tool to help extract the value from feed; E.lab, a broad range of laboratory analyses to help feed and premix producers control the quality of raw materials and additives; DIM, a full support program; MilkPay calculator; Milk$MART; and NESTOR, which is used to formulate net energy. It operates in China, Europe, the Middle East, Africa, the Indian subcontinent, North and south America, the Asia-Pacific regions. The company was founded in 1939 and is based in Beijing, China. Bluestar Adisseo Company operates as a subsidiary of China National Bluestar (Group) Co,Ltd.

Company Details

  • SectorBasic Materials
  • IndustrySpecialty Chemicals
  • CEODr. Zhigang Hao
  • Employees3.29K
  • HeadquartersNo. 9 West Beitucheng Road, Beijing, China, 100029, China
  • Websitehttps://www.adisseo.com

Leadership

  • Dr. Zhigang HaoCEO & Chairman · b. 1978
  • Mr. Frederic JacquinCOO & Deputy GM · b. 1967
  • Ms. Yun CaiSecretary to the Board · b. 1974
  • Mr. Jean-François RousDeputy General Manager · b. 1967
  • Mr. Bing Jing DingDeputy General Manager · b. 1982

Financials

Income Statement

Currency: CNY1997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue239.74M295.17M421.11M427.95M558.25M750.64M1.17B1.88B2.49B5.21B7.90B7.37B7.77B9.68B11.39B9.08B8.53B19.46B15.17B10.69B10.40B11.42B11.14B11.91B12.87B14.53B13.18B15.53B17.23B
Growth (%)-+23.12%+42.67%+1.62%+30.45%+34.46%+56.48%+60.07%+32.42%+109.44%+51.51%-6.72%+5.47%+24.49%+17.76%-20.28%-6.07%+128.12%-22.05%-29.56%-2.72%+9.81%-2.47%+6.96%+8.05%+12.90%-9.26%+17.83%+10.92%
Cost of Revenue190.83M235.68M339.33M343.13M465.24M636.23M998.81M1.59B1.95B4.40B6.76B6.81B7.19B8.64B10.45B5.58B5.61B15.35B9.01B5.65B6.34B7.45B7.36B7.40B8.48B10.63B10.38B10.87B12.35B
Gross Profit48.91M59.48M81.78M84.82M93.01M114.41M175.81M291.19M537.91M686.41M1.14B557.62M581.70M1.03B947.33M3.75B2.92B4.11B6.16B5.04B4.06B3.97B3.78B4.51B4.39B3.90B2.81B4.67B4.88B
Gross Margin20.40%20.15%19.42%19.82%16.66%15.24%14.97%15.49%21.60%13.16%14.47%7.57%7.48%10.68%8.31%41.25%34.23%21.12%40.62%47.18%39.01%34.75%33.94%37.86%34.11%26.87%21.28%30.03%28.31%
Operating Expense17.80M18.01M17.15M20.74M32.79M53.17M106.51M91.57M180.12M428.35M433.64M480.37M887.73M970.74M844.37M4.41B1.29B1.95B2.56B1.85B1.68B2.30B2.19B2.46B2.33B2.40B2.74B2.94B3.20B
Operating Income31.11M41.47M64.63M64.08M60.22M61.24M69.30M199.62M357.80M258.06M709.51M77.25M-306.03M62.40M102.97M-661.47M1.63B2.16B3.61B3.19B2.38B1.67B1.59B2.05B2.06B1.50B68.37M1.73B1.68B
Operating Margin12.98%14.05%15.35%14.97%10.79%8.16%5.90%10.62%14.37%4.95%8.98%1.05%-3.94%0.64%0.90%-7.28%19.12%11.08%23.77%29.86%22.89%14.60%14.27%17.17%16.05%10.34%0.52%11.11%9.73%
EBITDA34.54M44.80M80.73M103.98M118.37M159.10M240.85M329.47M492.29M654.94M1.01B510.37M461.37M600.38M609.37M2.89B2.13B3.13B5.19B4.01B3.04B2.68B2.47B3.26B3.25B2.90B1.90B3.20B3.20B
EBITDA Margin14.41%15.18%19.17%24.30%21.20%21.20%20.50%17.52%19.77%12.56%12.79%6.93%5.94%6.20%5.35%31.82%25.02%16.09%34.19%37.56%29.26%23.45%22.17%27.35%25.29%19.93%14.44%20.60%18.56%
Net Income26.65M35.05M61.45M61.62M48.71M50.31M58.16M99.86M216.44M205.80M418.08M-153.62M-159.45M75.49M71.56M-1.04B1.06B1.48B1.53B1.87B1.32B926.13M992.38M1.35B1.47B1.25B52.17M1.20B1.15B
Net Income Margin11.12%11.88%14.59%14.40%8.72%6.70%4.95%5.31%8.69%3.95%5.29%-2.08%-2.05%0.78%0.63%-11.44%12.46%7.58%10.07%17.45%12.73%8.11%8.91%11.35%11.44%8.58%0.40%7.75%6.70%
R&D-------------59.62M55.36M33.31M45.64M48.59M165.47M245.65M236.13M306.92M306.68M301.30M340.58M354.78M419.25M484.57M456.12M
R&D as % of Total Revenue-------------0.62%0.49%0.37%0.53%0.25%1.09%2.30%2.27%2.69%2.75%2.53%2.65%2.44%3.18%3.12%2.65%
Interest Expense3.43M3.53M2.98M11.78M15.46M31.05M57.64M95.13M119.58M144.95M201.82M250.13M221.75M257.86M343.24M449.50M471.63M761.07M375.70M30.23M29.17M24.44M38.89M13.82M32.86M72.75M134.15M131.60M54.22M
Interest Expense % of Total Revenue1.43%1.20%0.71%2.75%2.77%4.14%4.91%5.06%4.80%2.78%2.55%3.39%2.85%2.66%3.01%4.95%5.53%3.91%2.48%0.28%0.28%0.21%0.35%0.12%0.26%0.50%1.02%0.85%0.31%

Balance Sheet

Currency: CNY1997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets341.88M405.55M490.91M1.22B1.72B2.28B2.55B2.84B3.96B5.66B9.32B11.56B12.39B15.30B18.10B18.59B20.01B18.20B17.91B19.94B21.33B21.45B21.13B20.62B20.91B21.34B21.51B22.26B27.80B
Total Liabilities166.69M204.66M268.81M415.81M914.22M1.45B1.62B1.87B2.80B4.40B6.11B8.42B9.43B12.25B14.99B16.56B19.11B17.17B3.73B4.06B4.07B4.05B3.91B5.19B5.48B6.39B6.45B6.69B7.90B
Total Equity175.19M200.88M222.10M764.30M759.48M785.79M874.20M916.21M1.07B1.22B3.08B2.92B2.78B2.87B2.95B1.90B763.57M994.64M10.19B12.08B13.16B13.60B13.80B13.95B14.09B14.93B15.04B15.54B19.86B
Cash3.97M13.50M32.65M117.24M146.45M370.32M313.74M202.43M972.24M518.94M1.31B1.48B585.10M1.12B807.62M934.67M1.41B1.43B4.94B6.68B7.66B5.28B5.30B2.77B2.11B796.36M1.01B1.27B4.27B
Total Debt80.68M100.80M102.92M244.92M724.42M1.26B1.34B1.47B2.28B3.19B3.38B5.34B5.16B6.52B9.55B10.27B9.74B10.02B100.52M131.55M97.72M166.16M187.22M926.56M1.07B2.26B2.06B1.29B1.90B
Net Debt76.71M87.30M70.27M127.68M577.97M893.92M1.03B1.27B1.31B2.67B2.07B3.86B4.57B5.41B8.74B9.33B8.33B8.59B-4.84B-6.55B-7.56B-5.12B-5.11B-1.84B-1.04B1.47B1.05B28.47M-2.38B

Cash Flow

Currency: CNY1999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow73.18M-255.34M237.47M178.82M173.51M202.63M877.29M158.23M446.09M345.21M174.43M35.64M289.41M523.07M423.91M166.58M3.56B3.05B2.51B1.44B2.55B2.71B2.60B1.73B2.76B2.94B3.33B
Investing Cash Flow-50.75M-220.47M-653.91M-422.96M-243.15M-301.44M-629.09M-1.34B-822.56M-1.96B-1.57B-1.71B-2.21B-899.00M-732.86M-30.35M-997.05M-609.77M-900.55M-2.38B-1.16B-2.30B-2.44B-1.80B-1.86B-1.63B-3.25B
Financing Cash Flow18.12K560.40M445.65M468.01M13.06M-12.50M521.97M702.43M1.02B1.70B561.66M2.11B1.71B430.84M322.80M-358.15M798.52M-751.65M-880.07M-1.37B-1.36B-3.03B-630.68M-1.16B-797.82M-1.02B2.91B
Capital Expenditure50.75M220.53M651.18M423.86M243.16M306.10M505.06M1.14B947.85M2.01B1.57B1.73B2.48B1.07B857.39M752.42M1.01B602.59M965.97M1.26B1.24B1.32B2.31B1.54B1.45B1.62B3.70B
Free Cash Flow22.43M-475.87M-413.71M-245.04M-69.64M-103.47M372.23M-986.21M-501.76M-1.67B-1.39B-1.70B-2.19B-546.54M-433.48M-585.84M2.55B2.45B1.55B177.81M1.31B1.39B288.08M186.53M1.32B1.32B-371.61M
Dividends Paid2.15M63.37M34.79M71.77M93.38M142.55M180.72M173.75M316.09M247.38M359.07M254.80M325.93M806.08M800.18M538.73M439.23M410.81M628.24M480.91M740.20M418.38M472.01M538.98M525.35M281.89M578.46M
FCF to OCF30.65%186.37%-174.21%-137.03%-40.14%-51.06%42.43%-623.27%-112.48%-482.62%-799.59%-4761.43%-757.44%-104.49%-102.26%-351.68%71.67%80.27%61.56%12.33%51.38%51.34%11.07%10.79%47.65%44.88%-11.16%
Dividend Paid to FCF9.60%-13.32%-8.41%-29.29%-134.08%-137.77%48.55%-17.62%-63.00%-14.85%-25.74%-15.01%-14.87%-147.49%-184.59%-91.96%17.23%16.76%40.61%270.47%56.49%30.09%163.85%288.95%39.89%21.33%-155.66%

Earnings

Report DateJun 2, 2010Sep 1, 2010Dec 1, 2010Mar 2, 2011Jun 1, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Oct 19, 2014Feb 25, 2015Apr 19, 2015Aug 26, 2015Oct 23, 2015Mar 2, 2016Apr 15, 2016Jul 27, 2016Oct 28, 2016Mar 30, 2017Apr 28, 2017Jul 26, 2017Oct 27, 2017Jan 25, 2018Apr 24, 2018Jul 25, 2018Oct 24, 2018Feb 15, 2019Apr 24, 2019Jul 24, 2019Oct 23, 2019Feb 13, 2020Apr 22, 2020Jul 30, 2020Oct 29, 2020Feb 9, 2021Apr 29, 2021Jul 30, 2021Oct 28, 2021Mar 30, 2022Apr 28, 2022Jul 28, 2022Oct 27, 2022Feb 15, 2023Apr 26, 2023Aug 4, 2023Oct 27, 2023Mar 28, 2024Apr 25, 2024Aug 29, 2024Oct 29, 2024Feb 27, 2025Apr 28, 2025Aug 29, 2025Oct 30, 2025Mar 6, 2026
EPS Estimate-----------------------------------------0.150.140.160.150.230.180.210.180.200.160.140.190.180.110.190.070.100.140.110.170.180.160.13
EPS Actual0.000.050.10-0.010.090.16-0.130.02-0.39-0.56-0.65-0.39-0.46-0.52-0.41-0.80-0.43-0.53-0.281.70-0.38-1.021.340.110.210.200.170.120.120.100.120.150.130.050.080.080.110.090.100.070.110.160.150.100.140.170.170.080.160.160.100.03-0.010.01-0.020.020.100.130.150.080.170.110.090.06
Surprise-----------------------------------------6.67%7.14%-37.50%-6.67%-26.09%-5.56%-61.90%-11.11%-20.00%-37.50%-78.57%-105.26%-94.44%-118.18%-89.47%42.86%30.00%7.14%-27.27%0.00%-38.89%-43.75%-53.85%
Timing------------------After-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-market

Key Statistics & Ratios

Market Cap25.28B
Enterprise Value23.98B
Trailing P/E18.66
Forward P/E78.13
Price / Sales1.37
Price / Book1.31
EPS0.44
Book Value6.40
Revenue (TTM)18.43B
Gross Profit (TTM)5.14B
EBITDA3.34B
Profit Margin7.16%
Operating Margin15.99%
Return on Equity7.22%
Return on Assets4.96%
Shares Outstanding3.08B
Shares Float774.41M
Beta0.27
Dividend Yield1.84%
Dividend Rate0.15
Payout Ratio11.59%

Dividends

20231×
0.15Jul 13, 2023
20221×
0.18Jun 20, 2022
20211×
0.18Jun 17, 2021
20201×
0.16Jun 12, 2020
20192×
0.10Dec 19, 20190.17Jun 13, 2019
20181×
0.17Jun 13, 2018
20171×
0.23Jun 14, 2017
20161×
0.17Jun 8, 2016
20071×
0.15Jun 20, 2007
20062×
0.09Aug 11, 20062.04Aug 2, 2006
20051×
0.11Apr 26, 2005
20041×
0.10May 27, 2004
20031×
0.05May 26, 2003
20021×
0.05Jul 15, 2002
20011×
0.03Jul 31, 2001

Stock Splits

  • Jun 13, 200813:10
  • Aug 11, 20063:2